Clinical Trials Directory

Trials / Completed

CompletedNCT04468685

Ondansetron Effect on Pain Relief After Laparoscopic Cholecystectomy

Efficacy of Intraperitoneal Ondansetron Administration on Pain Relief After Laparoscopic Cholecystectomy

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
50 (actual)
Sponsor
National Hepatology & Tropical Medicine Research Institute · Other Government
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Laparoscopic cholecystectomy (LC) is an easy procedure characterized by its minimal invasiveness, less post-operative pain and early recovery when compared to the open conventional cholecystectomy. However, patients who have undergone LC still complain of postoperative pain. It has been reported that ondansetron produces numbness when injected under the skin and has local anesthetic effect that is 15 times more potent than lidocaine the most widely used local anesthetic and probably explains its antiemetic action. It possesses anti-inflammatory, anesthetic, and analgesic properties by its multifaceted actions as a 5-HT3 receptor antagonist, a Na channel blocker, and a mu-opioid agonist which may have a potential role in decreasing pain. The study aimed to demonstrate the effectiveness of IP administration of ondansetron on pain management post LC.

Conditions

Interventions

TypeNameDescription
DRUGOndansetronInterperitoneal administration in the gall bladder bed
DRUGNormal salineInterperitoneal administration in the gall bladder bed

Timeline

Start date
2020-07-15
Primary completion
2020-12-18
Completion
2020-12-18
First posted
2020-07-13
Last updated
2021-01-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04468685. Inclusion in this directory is not an endorsement.